Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment

被引:648
作者
Coll, E
Botey, A
Alvarez, L
Poch, E
Quintó, L
Saurina, A
Vera, M
Piera, C
Darnell, A
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Augyst Pi & Sunyer, Serv Nefrol, E-08036 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Augyst Pi & Sunyer, Serv Biochem, E-08036 Barcelona, Spain
[3] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Augyst Pi & Sunyer, Serv Stat, E-08036 Barcelona, Spain
[4] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Augyst Pi & Sunyer, Nucl Med Serv, E-08036 Barcelona, Spain
关键词
cystatin C; glomerular filtration rate (GFR); impaired renal function; early nephropathy;
D O I
10.1053/ajkd.2000.8237
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cystatin C is a nonglycosylated basic protein produced at a constant rate by all investigated nucleated cells. It is freely filtered by the renal glomeruli and primarily catabolized in the tubuli (not secreted or reabsorbed as an intact molecule). Because serum cystatin C concentration is independent of age, sex, and muscle mass, it has been postulated to be an improved marker of glomerular filtration rate (GFR) compared with serum creatinine level. We compared serum cystatin C level with other markers of GFR, such as serum creatinine level and creatinine clearance, and analyzed their variations based on iothalamate labeled with iodine 125 (I-125-iothalamate) clearance (I-125-ICI), used as the gold standard for GFR. The concentrations of the two different markers of GFR in patients with impaired renal function were classified according to I-125-ICI. Twenty individuals with normal renal function (I-125-ICI, 128 +/- 23 mL/min/1.73 m(2)) were used as the control group. Serum cystatin C level showed a greater sensitivity (93.4%) than serum creatinine level (86.8%). Also, serum cystatin C showed the greatest proportion of increased values in patients with impaired renal function (100%) compared with serum creatinine level (92.15%). Serum cystatin C levels started to increase to greater than normal values when GFR was 88 mL/min/1.73 m(2), whereas serum creatinine level began to increase when GFR was 75 mL/min/1.73 m2. These data suggest that measurement of serum cystatin C may be useful to estimate GFR, especially to detect mild reductions in GFR, and therefore may be important in the detection of early renal insufficiency in a variety of renal diseases for which early treatment is critical. (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 18 条
[1]  
Blaufox M D, 1972, Prog Nucl Med, V2, P107
[2]   CREATININE - AN INADEQUATE FILTRATION MARKER IN GLOMERULAR-DISEASES [J].
CARRIE, BJ ;
GOLBETZ, HV ;
MICHAELS, AS ;
MYERS, BD .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (02) :177-182
[3]   The excretion of urea in normal man and in subjects with glomerulonephritis [J].
Chasis, H ;
Smith, HW .
JOURNAL OF CLINICAL INVESTIGATION, 1938, 17 (03) :347-358
[4]   A CLINICAL APPRAISAL OF PLASMA CONCENTRATION AND ENDOGENOUS CLEARANCE OF CREATININE [J].
DOOLAN, PD ;
ALPEN, EL ;
THEIL, GB .
AMERICAN JOURNAL OF MEDICINE, 1962, 32 (01) :65-&
[5]   A formula to estimate the approximate surface area if height and weight be known [J].
Du Bois, D ;
Du Bois, EF .
ARCHIVES OF INTERNAL MEDICINE, 1916, 17 (06) :863-871
[6]   STUDY OF CREATINE METABOLISM IN DISEASES CAUSING MUSCLE WASTING [J].
FITCH, CD ;
SINTON, DW .
JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (03) :444-&
[7]   FACTORS INFLUENCING THE PRODUCTION OF CREATININE - IMPLICATIONS FOR THE DETERMINATION AND INTERPRETATION OF URINARY CREATININE AND CREATINE IN MAN [J].
FULLER, NJ ;
ELIA, M .
CLINICA CHIMICA ACTA, 1988, 175 (03) :199-210
[8]  
HILBRANDS LB, 1992, LANCET, V340, P1326
[9]   A LONGITUDINAL-STUDY OF URINARY CREATININE AND CREATININE CLEARANCE IN NORMAL SUBJECTS - RACE, SEX, AND AGE-DIFFERENCES [J].
JAMES, GD ;
SEALEY, JE ;
ALDERMAN, M ;
LJUNGMAN, S ;
MUELLER, FB ;
PECKER, MS ;
LARAGH, JH .
AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (02) :124-131
[10]  
KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921